KEMARIN
SEVENTEEN
(Intro) Am G F
Am G F
Am Dm
Kemarin engkau masih ada disini
G C
Bersamaku menikmati rasa ini
F Bm
Berharap semua takkan pernah berakhir
E E
Bersamamu..bersamamu
Am Dm
Kemarin dunia terlihat sangat indah
G C
Dan denganmu merasakan ini semua
F Bm
Melewati hitam putih hidup ini
E E
Bersamamu..bersamamu
(Chorus)
Am Dm
Kini sendiri disini
G C
Mencarimu tak tahu dimana
Dm Bm E
S'moga tenang kau disana selamanya..
Am Dm
Aku s'lalu mengingatmu
G C
Doakanmu setiap malamku
Dm Bm E
S'moga tenang kau disana selamanya..
(Interlude) F Dm Em Am
F Dm E
Eo.. wo..
(Chorus)
Am Dm
Kini sendiri disini
G C
Mencarimu tak tahu dimana
Dm Bm E
S'moga tenang kau disana selamanya..
Am Dm
Aku s'lalu mengingatmu
G C
Doakanmu setiap malamku
Dm Bb Bm E E
S'moga tenang.. kau disana.. selamanya..
Am G F G
ho.. wo wo..
(Outro) Am G F G Am
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment